Research is being conducted to systemically study the regulation of p21’s expression upstream and downstream at different levels (transcriptionally, post-transcriptionally, and post-translationally) and contribute with therapeutic approaches against cancer and drug resistance treatments[117]. This evidence concerns the gene CDKN1A and cancer.